Clinical outcomes following dalbavancin administration in patients with barriers to outpatient parenteral antimicrobial therapy

Between 2016 and 2021, we retrospectively identified 42 patients receiving ≥1 dose of dalbavancin for osteomyelitis, skin and soft-tissue infection, endocarditis or bacteremia, or septic arthritis. Median antibiotic duration prior to dalbavancin administration was 7 days. Within 90 days, 93% achieve...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Jessica J. Tuan (Author), Jehanzeb Kayani (Author), Ann Fisher (Author), Brian Kotansky (Author), Louise-Marie Dembry (Author), Rupak Datta (Author)
Formato: Livro
Publicado em: Cambridge University Press, 2022-01-01T00:00:00Z.
Assuntos:
Acesso em linha:Connect to this object online.
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!